On January 12, 2012, Labco S.A.S., a private limited liability company (société par actions simplifiée) converted its corporate form into a société anonyme. References to Labco S.A.S. in the name of the Issuer have now changed to Labco S.A.

Labco S.A., has completed a private placement of EUR 100 million in aggregate principal amount of its 8.5% senior secured notes due 2018. Kirkland & Ellis International LLP acted as legal advisor to the company. The notes constitute a further issuance of, and will form a single class with, Labco's existing 8.5% senior secured notes due 2018. The notes are being offered only to qualified institutional buyers and will mature on January 15, 2018.

According to banking sources, a consortium led by 3i Group plc has begun the process to sell a majority stake in Labco S.A.S. The sources added that the potential sale could fetch approximately €1 billion. The consortium includes TCR Capital, Natixis Investissement Partners and CIC Finance. The consortium appointed Rothschild Inc. to assist in the sale process. The sources said that Bain Capital, LLC, TowerBrook Capital Partners L.P., The Blackstone Group LP, EQT Partners AB and PAI Partners are among private equity firms that are interested to bid for Labco. The sources did not disclose any information about the size of stake that is up for sale. Reuters said that 3i declined to comment on the matter. Bankers added that private equity firms from healthcare sector are expected to show interest for Labco.